United Therapeutics Corporation (UTHR)

Last Closing Price: 318.85 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

United Therapeutics Corporation (UTHR) had Net Income of $1.20B for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$2.88B
Net Income
$1.20B
$309.70M
$2.57B
$1.50B
$1.38B
$162.00M
$1.54B
$1.54B
$1.20B
$1.20B
$1.20B
$1.20B
$1.38B
$1.45B
45.20M
48.50M
$26.44
$24.64
Balance Sheet Financials
$3.87B
$1.22B
$3.49B
$7.36B
$738.10M
--
$181.90M
$920.00M
$6.44B
$6.33B
$6.44B
44.83M
Cash Flow Statement Financials
$1.33B
$417.20M
$-1.25B
$1.21B
$1.70B
$489.50M
$144.00M
--
--
Fundamental Metrics & Ratios
5.25
--
--
--
0.05
89.24%
47.86%
47.86%
50.38%
53.49%
41.53%
$1.08B
--
--
--
0.39
1.96
10.30
35.43
18.55%
18.87%
16.23%
18.55%
$143.74
$22.28
$27.36